IndiGo Posts Record Quarterly Loss Of Rs 1,195 Crore On Pandemic Hit
Interglobe Aviation Ltd, which runs the country's largest airline IndiGo, reported its record quarterly loss on Thursday as pandemic-related travel restrictions continued to dent its operations. The company's second-quarter net loss came in at Rs 1,195 crore, compared with a loss of Rs 1,066 crore last year.
IndiGo's EBITDAR (Earnings before finance income and cost, tax, depreciation, amortization and aircraft and engine rentals) or operating profit rose 59 per cent annually to Rs 408.5 crore and EBITDAR margin came in at 14.9 per cent, the Gurugram-based airline said.
IndiGo's total fleet of aircrafts stood a 282 planes, the company said.
The global aviation industry has been among the worst hit by the pandemic and related travel restrictions.
The airline said it expects third-quarter average seat kilometers (ASKs) to be around 60 per cent of its ASKs for the same quarter a year earlier.
"We are slowly but surely stair-stepping our way back to normal capacity," Chief Executive Officer Ronojoy Dutta said in a statement.
"Once we are back at 100 per cent capacity, we will have lower unit costs, a stronger product, more efficient fleet and a robust network," he said.
IndiGo, which dominates the domestic market, said its total debt as of September stood at Rs 25,419.4 crore, up 28 per cent from last year.
In June, IndiGo said it would cut up to Rs 4,000 crore in costs and speed up the return of older planes to leasing companies in an attempt to cope with the pandemic-incurred hit to business.
Revenue from operations plunged 66 per cent to Rs 2,741 crore, the airline operator said on Thursday.
Interglobe Aviation shares ended 3.11 per cent higher at Rs 1,333 ahead of the earnings announcement.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.